論文・技術情報追加のお知らせ

①Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy.

PD-1阻害剤による免疫関連有害事象リスク予測探索

対象DB：FAERS

②Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system.

固形臓器移植患者における免疫チェックポイント阻害剤投与後の同種移植片拒絶反応

対象DB：FAERS

③Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

光線性角化症患者におけるインゲノールメブテートによる扁平上皮癌との関連性調査研究

対象DB：FAERS

④Hepatitis B Virus Reactivation in Cancer Patients Undergoing Immune Checkpoint Inhibitors Therapy: A Systematic Review.

進行がん患者における免疫チェックポイント阻害剤とB型肝炎ウィルス活性との関連調査研究

対象DB：FAERS

⑤A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax.

ベネトクラクスによる有害事象ファーマコビジランス研究

対象DB：FAERS

⑥Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS).

抗VEGF療法に伴う眼部の有害事象調査研究

対象DB：FAERS